Tranexamic Acid Reduces Red Cell Transfusion Better than &egr;-Aminocaproic Acid or Placebo in Liver Transplantation
暂无分享,去创建一个
E. Jaurrieta | P. Parrilla | M. Koo | A. Sabaté | A. Dalmau | A. Rafecas | J. Figueras | T. Sansano | L. García-Huete | F. Acosta
[1] R. Rossaint,et al. Coagulation techniques are not important in directing blood product transfusion during liver transplantation. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[2] M. Ramsay. The use of antifibrinolytic agents results in a reduction in transfused blood products during liver transplantation. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[3] R. P. Kufner. Antifibrinolytics do not reduce transfusion requirements in patients undergoing orthotopic liver transplantation. , 1997, Liver Transplantation and Surgery.
[4] E. Jaurrieta,et al. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: A randomized clinical study , 1997, Hepatology.
[5] Y. Kang. Coagulation and liver transplantation: current concepts. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] A. Sandler,et al. Tranexamic Acid Reduces Blood Loss, Transfusion Requirements, and Coagulation Factor Use in Primary Orthotopic Liver Transplantation , 1996, Anesthesiology.
[7] R. Freeman,et al. Transesophageal echocardiography reveals an unusual cause of hemodynamic collapse during orthotopic liver transplantation--two case reports. , 1995, Transplantation.
[8] K. Boudjema,et al. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients. , 1994, British journal of anaesthesia.
[9] S. Bélisle,et al. Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency , 1994, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[10] M. Csete,et al. One Thousand Liver Transplants The Lessons Learned , 1994, Annals of surgery.
[11] Yoogoo Kang,et al. Coagulation and Liver Transplantation , 1993, Transplantation proceedings.
[12] M. Welte,et al. Does aprotinin affect blood loss in liver transplantation? , 1992, The Lancet.
[13] K. Taraporewalla,et al. Does prophylactic epsilon-aminocaproic acid improve blood loss and coagulation in liver transplantation? , 1991, Transplantation proceedings.
[14] S. Mallett,et al. Aprotinin and reduction of blood loss and transfusion requirements in orthotopic liver transplantation , 1990, The Lancet.
[15] K. Boudjema,et al. Organ preservation: experience with University of Wisconsin solution and plans for the future. , 1990, Clinical transplantation.
[16] T. Starzl,et al. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. , 1989, Transplantation.
[17] R. Jenkins,et al. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. , 1988, Blood.
[18] T. Starzl,et al. Epsilon‐aminocaproic Acid for Treatment of Fibrinolysis during Liver Transplantation , 1987, Anesthesiology.
[19] D. V. van Thiel,et al. THE RELATION OF PREOPERATIVE COAGULATION FINDINGS TO DIAGNOSIS, BLOOD USAGE, AND SURVIVAL IN ADULT LIVER TRANSPLANTATION , 1985, Transplantation.
[20] G. Klintmalm,et al. The impact of operative bleeding on outcome in transplantation of the liver. , 1993, Surgery, gynecology & obstetrics.
[21] A. A. Tverskoi. [Hemostasis in liver transplantation]. , 1992, Anesteziologiia i reanimatologiia.